From 11th -14th September 2017 , Siena, Italy. Organized by the University of Siena and directed by Dr. Sandra Nuti. The advanced course in flow cytometry will be of particular relevance…
The Sao Paulo School of Advanced Sciences on Vaccines will provide participants with a critical and comprehensive view of the state of the art in vaccine research.…
The aim is to promote and foster a younger generation of scientists in the early stages of their career in Europe. The scope of the…
The U.S. Food and Drug Administration announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused…
Il progetto internazionale è finanziato da Innovative Medicines Initiative (IMI), partnership tra Unione Europea e Federazione Europea delle Industrie e delle Associazioni Farmaceutiche (EFPIA). Source: https://www.panoramasanita.it/2015/01/16/lotta-allebola-parte-da-siena-lo-studio-per-sviluppare-uno-dei-tre-vaccini-giudicati-piu-promettenti-dalloms/
Repubblica_vaccini141117_press-releaseDownload
Une équipe internationale de chercheurs dirigée par la professeure Claire-Anne Siegrist a mis au point ce qu’on appelle désormais “la formule de Genève”. Cette technique…
Innovative Medicines Initiative (IMI) is launching first eight projects on Ebola, covering vaccine development and manufacture, vaccine uptake, and diagnostics. Projects are part of the…
L’Unione Europea ha annunciato nuovi interventi a sostegno della ricerca sull’Ebola. Per rispondere all’emergenza saranno finanziati con un budget complessivo di 215 milioni di euro 8 progetti di…